Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China
· Delayed Price · Currency is CNY 1.730
+0.020 (1.17%)
Apr 29, 2026, 3:00 PM CST
Kangmei Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,240 | 977.84 | 1,057 | 1,507 | 2,419 | Upgrade
|
| Trading Asset Securities | 0.09 | 0.08 | 0.08 | 0.12 | 0.52 | Upgrade
|
| Cash & Short-Term Investments | 1,240 | 977.92 | 1,057 | 1,508 | 2,419 | Upgrade
|
| Cash Growth | 26.82% | -7.45% | -29.90% | -37.68% | 337.98% | Upgrade
|
| Accounts Receivable | 2,424 | 2,542 | 2,249 | 2,046 | 1,460 | Upgrade
|
| Other Receivables | 451.27 | 823.86 | 874.44 | 888.79 | 1,052 | Upgrade
|
| Receivables | 2,876 | 3,366 | 3,123 | 2,935 | 2,512 | Upgrade
|
| Inventory | 2,237 | 2,510 | 2,644 | 2,751 | 3,195 | Upgrade
|
| Prepaid Expenses | - | - | - | 0 | - | Upgrade
|
| Other Current Assets | 299.05 | 45.65 | -14.11 | 190.85 | 158.8 | Upgrade
|
| Total Current Assets | 6,651 | 6,900 | 6,810 | 7,384 | 8,285 | Upgrade
|
| Property, Plant & Equipment | 3,451 | 3,500 | 3,875 | 4,180 | 4,642 | Upgrade
|
| Long-Term Investments | 1.04 | 1.11 | 1.15 | 1.39 | 1 | Upgrade
|
| Goodwill | 36.91 | 106.35 | 106.35 | 106.35 | 106.35 | Upgrade
|
| Other Intangible Assets | 413.93 | 409.47 | 491.02 | 529.79 | 579.73 | Upgrade
|
| Long-Term Deferred Tax Assets | 64.17 | 74.36 | 101.48 | 96.97 | 60.69 | Upgrade
|
| Long-Term Deferred Charges | 49.99 | 55.05 | 66.47 | 86.71 | 110.22 | Upgrade
|
| Other Long-Term Assets | 2,551 | 2,752 | 2,829 | 2,783 | 2,269 | Upgrade
|
| Total Assets | 13,220 | 13,798 | 14,280 | 15,169 | 16,054 | Upgrade
|
| Accounts Payable | 2,355 | 2,546 | 2,256 | 2,563 | 2,015 | Upgrade
|
| Accrued Expenses | 70.85 | 520.42 | 716.97 | 1,328 | 1,134 | Upgrade
|
| Short-Term Debt | 90.93 | 15.83 | 26.14 | 25.62 | 15.17 | Upgrade
|
| Current Portion of Long-Term Debt | 23.54 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 28.35 | 40.71 | 39.12 | 36.89 | Upgrade
|
| Current Income Taxes Payable | 425.57 | 27.7 | 24.74 | 26.2 | 140.5 | Upgrade
|
| Current Unearned Revenue | 91.7 | 118.82 | 159.89 | 158.12 | 193.85 | Upgrade
|
| Other Current Liabilities | 2,208 | 2,637 | 2,875 | 1,301 | 1,411 | Upgrade
|
| Total Current Liabilities | 5,266 | 5,894 | 6,100 | 5,442 | 4,947 | Upgrade
|
| Long-Term Leases | 69.89 | 94.95 | 188.16 | 199.13 | 153.22 | Upgrade
|
| Long-Term Unearned Revenue | 523.01 | 555.78 | 618.68 | 653.98 | 692.97 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 19.3 | 26.85 | 51.68 | 55.53 | - | Upgrade
|
| Other Long-Term Liabilities | 16.25 | 17.79 | 241.31 | 1,835 | 293.02 | Upgrade
|
| Total Liabilities | 5,894 | 6,589 | 7,200 | 8,185 | 6,086 | Upgrade
|
| Common Stock | 13,829 | 13,864 | 13,864 | 13,864 | 13,864 | Upgrade
|
| Additional Paid-In Capital | 18,474 | 18,783 | 18,783 | 18,783 | 18,783 | Upgrade
|
| Retained Earnings | -24,356 | -24,367 | -24,375 | -24,478 | -21,790 | Upgrade
|
| Treasury Stock | -659.92 | -1,107 | -1,225 | -1,222 | -932.82 | Upgrade
|
| Comprehensive Income & Other | 3.23 | 1.18 | 1.18 | 1.43 | 3.1 | Upgrade
|
| Total Common Equity | 7,290 | 7,174 | 7,048 | 6,948 | 9,927 | Upgrade
|
| Minority Interest | 35.4 | 34.55 | 32.89 | 35.43 | 41.92 | Upgrade
|
| Shareholders' Equity | 7,325 | 7,209 | 7,080 | 6,984 | 9,968 | Upgrade
|
| Total Liabilities & Equity | 13,220 | 13,798 | 14,280 | 15,169 | 16,054 | Upgrade
|
| Total Debt | 184.36 | 139.13 | 255.01 | 263.87 | 205.29 | Upgrade
|
| Net Cash (Debt) | 1,056 | 838.8 | 801.68 | 1,244 | 2,214 | Upgrade
|
| Net Cash Growth | 25.87% | 4.63% | -35.54% | -43.82% | - | Upgrade
|
| Net Cash Per Share | 0.07 | 0.06 | 0.08 | 0.09 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 19,770 | 13,864 | 13,864 | 13,864 | 13,864 | Upgrade
|
| Total Common Shares Outstanding | 19,770 | 13,864 | 13,864 | 13,864 | 13,864 | Upgrade
|
| Working Capital | 1,386 | 1,007 | 709.67 | 1,942 | 3,338 | Upgrade
|
| Book Value Per Share | 0.37 | 0.52 | 0.51 | 0.50 | 0.72 | Upgrade
|
| Tangible Book Value | 6,839 | 6,658 | 6,450 | 6,312 | 9,240 | Upgrade
|
| Tangible Book Value Per Share | 0.35 | 0.48 | 0.47 | 0.46 | 0.67 | Upgrade
|
| Buildings | - | 5,119 | 5,229 | 5,401 | 5,665 | Upgrade
|
| Machinery | - | 1,162 | 1,162 | 826.65 | 1,206 | Upgrade
|
| Construction In Progress | - | 175.32 | 210.56 | 215.5 | 263.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.